Home › Funds › NAN FUNG TRINITY (HK) Ltd › IMNM

NAN FUNG TRINITY (HK) Ltd position in IMNM

IMMUNOME INC · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 621,079 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$13.4M, representing 1.28% of its reported portfolio and ranking #33 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed IMNM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)621.08K sh
Reported value held$13.36M
Portfolio Weight1.28%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's IMNM position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in IMNM in Q2 2025 at 548,850 shares (US$5.1M). The position peaked in Q1 2026 at 714,553 shares, worth US$15.6M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 621,079 shares valued at US$13.4M — a reduction of -93,474 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 548.85K $5.10M New
Q3 2025 592.10K $6.93M Add
Q4 2025 714.55K $15.35M Add
Q1 2026 714.55K $15.63M Hold
Q2 2026 714.55K $15.14M Hold
Q3 2026 621.08K $13.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMNM and 13F data

IMNM (IMMUNOME INC) is a Health Care company. 42 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$45.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMNM

All IMNM fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held IMNM?

NAN FUNG TRINITY (HK) Ltd has disclosed IMNM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in IMNM?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 621.08K shares of IMNM (IMMUNOME INC), valued at $13.36M, representing 1.28% of its reported portfolio and ranking #33.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling IMNM?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd reduced its position in IMNM. The position peaked in Q1 2026 at 714.55K shares.

Which other funds hold IMNM?

Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.